Charles Loprinzi, M.D., a Mayo Clinic medical oncologist, played aleadership rolein this work in conjunction with Rudolph Navari, M.D., of The University of Alabama at Birmingham. "It's well-appreciated by most people that patients receivingcancerchemotherapy suffer fromnauseaand vomiting," exp...
Charles Loprinzi, M.D., a Mayo Clinic medical oncologist, played aleadership rolein this work in conjunction with Rudolph Navari, M.D., of The University of Alabama at Birmingham. "It's well-appreciated by most people that patients receivingcancerchemotherapy suffer fromnauseaand vomiting," exp...
Olanzapine has a high affinity for the 5HT 2A receptor, which is up to 5 times greater than the dopamine receptor, resulting in less propensity to the development of extrapyramidal side effects. The affinity of olanzapine for multiple receptors has lead to the identification of olanzapine as an ...
sulfacetamide, imipramine, EGCG, PD 81723, olanzapine, and indirubin) had no discernable effects on cell viability or on neuronal morphology at 9 dpe (Fig.3e). However, two compounds, idarubicin and epirubicin,
Richelson, Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida, USA; R.C. Shelton, Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Data Selection Sources: Medical literature published in any language since 1980 on olanzapine, identified ...
a cognitive indicator) was not impaired after a morning dose of olanzapine 5mg alone or in combination with imipramine 75mg in healthy volunteers and short-term effects on alertness and motor effects showed rapid adaptation to treatment. In healthy volunteers olanzapine showed sleep-promoting effects....
Rudolph M. NavariSimon Williamson Clinic, Birmingham, AL;Jennifer Le-RademacherMayo Clinic, Department of Biostatistics, Rochester, MN;Fabrice SmieliauskasUniversity of Chicago, Chicago, IL;Kathryn Jean RuddyDepartment of Medical Oncology, Mayo Clinic, Rochester, MN;Thomas James Saphner...
side effects while retaining their potent anti-amyloid properties. Sulfacetamide and EGCG produced a slight increase in cell viability at some concentrations, suggesting that they may be neuroprotective. We next examined the effects of the six non-toxic compounds on Aβ neuropathology. At 9 dpe, ...